Bullock; William H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bullock; William H..The latest application filed is for "indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation".

Company Profile

0.17.18

Bullock; William H. - Easton CT US
Bullock, William H - Easton CT
Bullock; William H. - Orange CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 8,552,203 - Lowe , et al. October 8, 2	2013-10-08
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 8,541,618 - Lowe , et al. September 24, 2	2013-09-24
Indane Acetic Acid Derivatives And Their Use As Pharmaceutical Agents, Intermediates, And Method Of Preparation App 20110152331 - Lowe; Derek B. ; et al.	2011-06-23
Indane Acetic Acid Derivatives And Their Use As Pharmaceutical Agents, Intermediates, And Method Of Preparation App 20110152330 - Lowe; Derek B. ; et al.	2011-06-23
Indane Acetic Acid Derivatives And Their Use As Pharmaceutical Agents, Intermediates, And Method Of Preparation App 20110065129 - Lowe; Derek B. ; et al.	2011-03-17
Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation App 20090047687 - Lowe; Derek B. ; et al.	2009-02-19
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,358,386 - Lowe , et al. April 15, 2	2008-04-15
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,112,597 - Lowe , et al. September 26, 2	2006-09-26
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 7,109,196 - Wang , et al. September 19, 2	2006-09-19
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation App 20060205723 - Lowe; Derek B. ; et al.	2006-09-14
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20060189609 - Wang; Yamin ; et al.	2006-08-24
1,6-naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,964,971 - Wang , et al. November 15, 2	2005-11-15
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20050215594 - O'Connor, Stephen J. ; et al.	2005-09-29
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,919,371 - O'Connor , et al. July 19, 2	2005-07-19
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,900,205 - Wang , et al. May 31, 2	2005-05-31
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation App 20050075338 - Lowe, Derek B. ; et al.	2005-04-07
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 6,828,335 - Lowe , et al. December 7, 2	2004-12-07
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040209866 - Wang, Yamin ; et al.	2004-10-21
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents Grant 6,787,651 - Stolle , et al. September 7, 2	2004-09-07
1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040157875 - Wang, Yamin ; et al.	2004-08-12
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20040072828 - O'Connor, Stephen J. ; et al.	2004-04-15
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists Grant 6,699,860 - Ladouceur , et al. March 2, 2	2004-03-02
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040014751 - Wang, Yamin ; et al.	2004-01-22
1,6-naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,677,352 - Wang , et al. January 13, 2	2004-01-13
Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents App 20030229072 - Bullock, William H ; et al.	2003-12-11
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,660,752 - O'Connor , et al. December 9, 2	2003-12-09
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation App 20030216391 - Lowe, Derek B. ; et al.	2003-11-20
Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents App 20030207865 - Dixon, Brian R. ; et al.	2003-11-06
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents App 20030087902 - Stolle, Andreas ; et al.	2003-05-08
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20030078260 - O'Connor, Stephen J. ; et al.	2003-04-24
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists App 20030078258 - Ladouceur, Gaetan H. ; et al.	2003-04-24
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents Grant 6,353,006 - Dixon , et al. March 5, 2	2002-03-05
Invalid walker with brakes Grant 4,029,311 - Chanslor , et al. June 14, 1	1977-06-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.